BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months

Empagliflozin: trial readouts and FDA decisions

2 upcoming industry Phase 2/3 readout(s) in the next 90 days, 0 upcoming FDA event(s), 3 readout(s) in the last 180 days and 0 FDA event(s) in the last 12 months. Sponsors: Boehringer Ingelheim, EMS, Celltrion. Drug names come from ClinicalTrials.gov intervention names and FDA records, lightly normalised; one drug can appear under several names (code, generic, brand).

Upcoming trial readouts

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2026-12 est.P3CelltrionNCT07093476 Efficacy and Safety of Add-On Therapy With Empagliflozin in Patients With Type 2 Diabetes on a Background of Alogliptin and MetforminT2DM; Diabete Type 2; DMrecruiting171
2026-12-31 est.P3Boehringer IngelheimNCT06531824 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)Kidney Disease, Chronicactive not recruiting8371

Readouts, last 180 days

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2026-08-14P2Boehringer IngelheimNCT06926660 A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney DiseaseChronic Kidney Diseasecompleted492
2026-07 est.P3EMSNCT05028140 Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes MellitusType II Diabetesrecruiting480
2026-07 est.P3EMSNCT04670666 Efficacy and Safety of Madalena Association in the Treatment of Type II Diabetes MellitusType 2 Diabetes Mellitusrecruiting270

Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA (openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score. Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP readout_calendar / fda_decisions. Not investment advice.